MedTrace Logo

Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products

NCT05109104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2024-04-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint and CAP Mountain Berry) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

Conditions

  • Sunscreening Agents

Interventions

DRUG

CAP UnScented

Sunscreen lip balm.

DRUG

CAP Herbal Mint

Sunscreen lip balm.

DRUG

CAP Mountain Berry

Sunscreen lip balm.

DRUG

SPF Standard Sunscreen

SPF Standard (7 percent \[%\] Padimate-O and 3% Oxybenzone)

Sponsors & Collaborators

  • HALEON

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-08
Primary Completion
2021-12-15
Completion
2021-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05109104 on ClinicalTrials.gov